A recent study indicates that individuals who come off new slimming jabs like Mounjaro or Wegovy tend to recover shed pounds much more quickly than those who stop traditional diet and exercise regimens.
Findings released in a leading health publication points out that while overweight people can lose substantial amounts of their body weight while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month once they quit.
"Users using these treatments should be informed of the potential of quick weight regain when the treatment is stopped," warns lead investigator Dr. Susan Jebb.
This pace of regain implies a reversion to starting mass in about one and a half years.
Weighing Therapies
The research, which looked at dozens of trials involving thousands of patients, contrasted the results of GLP-1 agonists with older methods.
The team note that people who lose weight through lifestyle changes alone typically see a slower weight regain—around 100 grams monthly—after stopping.
The Reason for the Quick Regain
Nutrition scientists believe the mode of action of the injections accounts for the heightened weight return.
GLP-1 drugs mimic a natural hormone called GLP-1, which moderates appetite.
"Sustained high doses of GLP-1 levels several times higher than normal could lead to the body to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication leads to appetite is no longer kept in check, making overeating much more probable."
A Chronic Condition?
Health authorities recommend the injections for people with obesity-related medical conditions, alongside prescribed lifestyle changes.
Many experts say that, considering the likelihood of relapse, the therapy should be considered long-term.
This opinion is supported by pharmaceutical companies, who note that the results "highlight the persistent character of obesity," akin to managing conditions like hypertension.
Patient Experiences
People who have stopped the medication describe a intense resurgence of hunger.
"I experienced a switch activating and I was suddenly ravenous," said an individual.
The struggle is exacerbated if users have not established sustainable lifestyle or habit modifications during therapy.
Significant Use
Survey data indicate that a significant number of people in the UK have tried weight-loss jabs in the past year, with interest being substantial.
- Use is higher among females compared to males.
- The middle-aged demographic shows the highest usage rates.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, experts caution that while the jabs are potent agents for shedding pounds, they are not a standalone solution and lasting health benefits hinges on ongoing lifestyle support.
